These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 32863941)
1. DNA methylation downregulated ZDHHC1 suppresses tumor growth by altering cellular metabolism and inducing oxidative/ER stress-mediated apoptosis and pyroptosis. Le X; Mu J; Peng W; Tang J; Xiang Q; Tian S; Feng Y; He S; Qiu Z; Ren G; Huang A; Lin Y; Tao Q; Xiang T Theranostics; 2020; 10(21):9495-9511. PubMed ID: 32863941 [TBL] [Abstract][Full Text] [Related]
2. The epigenetically downregulated factor CYGB suppresses breast cancer through inhibition of glucose metabolism. Feng Y; Wu M; Li S; He X; Tang J; Peng W; Zeng B; Deng C; Ren G; Xiang T J Exp Clin Cancer Res; 2018 Dec; 37(1):313. PubMed ID: 30545372 [TBL] [Abstract][Full Text] [Related]
3. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer. Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735 [TBL] [Abstract][Full Text] [Related]
4. ZDHHC1 downregulates LIPG and inhibits colorectal cancer growth via IGF2BP1 Palmitoylation. Zhang Q; Du Z; Zhou W; Li W; Yang Q; Yu H; Liu T Cancer Gene Ther; 2024 Sep; 31(9):1427-1437. PubMed ID: 39069526 [TBL] [Abstract][Full Text] [Related]
5. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer. Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876 [TBL] [Abstract][Full Text] [Related]
6. DNA methylation-mediated suppression of TUSC1 expression regulates the malignant progression of esophagogastric junction cancer. Liu Z; Xia G; Liang X; Li B; Deng J Clin Epigenetics; 2024 Jul; 16(1):97. PubMed ID: 39044262 [TBL] [Abstract][Full Text] [Related]
7. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53. Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734 [TBL] [Abstract][Full Text] [Related]
8. MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway. Wu H; Li J; Guo E; Luo S; Wang G Cell Physiol Biochem; 2018; 48(2):461-474. PubMed ID: 30016800 [TBL] [Abstract][Full Text] [Related]
9. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression. Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422 [TBL] [Abstract][Full Text] [Related]
10. PAX3 is a novel tumor suppressor by regulating the activities of major signaling pathways and transcription factor FOXO3a in thyroid cancer. Liu W; Sui F; Liu J; Wang M; Tian S; Ji M; Shi B; Hou P Oncotarget; 2016 Aug; 7(34):54744-54757. PubMed ID: 27458157 [TBL] [Abstract][Full Text] [Related]
11. The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling. Tao C; Luo J; Tang J; Zhou D; Feng S; Qiu Z; Putti TC; Xiang T; Tao Q; Li L; Ren G Clin Epigenetics; 2020 Nov; 12(1):173. PubMed ID: 33203470 [TBL] [Abstract][Full Text] [Related]
12. The novel DNA methylation marker FIBIN suppresses non-small cell lung cancer metastasis by negatively regulating ANXA2. Peng M; Yang L; Liao J; Le X; Dai F; Sun R; Wu F; Jiang Y; Tian R; Shao B; Zhou L; Wu M; Guo S; Xiang T Cell Signal; 2024 Aug; 120():111197. PubMed ID: 38697447 [TBL] [Abstract][Full Text] [Related]
13. Zinc-finger protein 545 inhibits cell proliferation as a tumor suppressor through inducing apoptosis and is disrupted by promoter methylation in breast cancer. Xiao Y; Xiang T; Luo X; Li C; Li Q; Peng W; Li L; Li S; Wang Z; Tang L; Ren G; Tao Q PLoS One; 2014; 9(10):e110990. PubMed ID: 25360542 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis. Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of zinc finger DHHC-type containing 1 is associated with poor prognosis and cancer cell growth and metastasis in uterine corpus endometrial carcinoma. Jiang N; Li D; Han Y; Luo ZG; Liu LB Aging (Albany NY); 2024 Jun; 16(11):9784-9812. PubMed ID: 38848146 [TBL] [Abstract][Full Text] [Related]
16. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer. Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105 [TBL] [Abstract][Full Text] [Related]
17. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
18. Protocadherin-10 acts as a tumor suppressor gene, and is frequently downregulated by promoter methylation in pancreatic cancer cells. Qiu C; Bu X; Jiang Z Oncol Rep; 2016 Jul; 36(1):383-9. PubMed ID: 27176920 [TBL] [Abstract][Full Text] [Related]
19. Targeting multiple pro-apoptotic signaling pathways with curcumin in prostate cancer cells. Rivera M; Ramos Y; Rodríguez-Valentín M; López-Acevedo S; Cubano LA; Zou J; Zhang Q; Wang G; Boukli NM PLoS One; 2017; 12(6):e0179587. PubMed ID: 28628644 [TBL] [Abstract][Full Text] [Related]
20. Neuronal pentraxin II (NPTX2) hypermethylation promotes cell proliferation but inhibits cell cycle arrest and apoptosis in gastric cancer cells by suppressing the p53 signaling pathway. Xu G; Fan L; Zhao S; OuYang C Bioengineered; 2021 Dec; 12(1):1311-1323. PubMed ID: 33896384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]